A new IL-12 Immunotherapy Study for Dogs with Soft Tissue Sarcoma

Frontiers Adoptive Natural Killer Cell Immunotherapy for Canine

Activities of IL-12 fusion proteins. A, IL-12 bioactivity as

A new IL-12 Immunotherapy Study for Dogs with Soft Tissue Sarcoma

JCM, Free Full-Text

Pharmaceutics, Free Full-Text

IJMS, Free Full-Text

Is immunotherapy in the future of therapeutic management of

Expanded Dog NK Cells are Cytotoxic against Canine Patient-Derived

Canine Clinical Trials

Canine Sarcoma: An Overview of Cancer Immunotherapy

Imaging of STSA-1 tumors (A, C) and canine soft tissue sarcoma

Tumor-localized interleukin-2 and interleukin-12 combine with